About Panacea Life Sciences Limited
Panacea Life Sciences Limited is a Chemicals & Materials company. Manufacturing and trading of pharmaceuticals, diagnostics, medicines, and chemicals in India. It operates in the Chemicals & Materials and Healthcare sectors. Its Indian entity Panacea Life Sciences Limited reported revenue of ₹20.85 Cr. Panacea Life Sciences Limited offers products and services including Drugs and Pharmaceuticals and Chemicals. Its focus areas include Chemicals, Industrial Chemicals, Chemical Trading and Organic and Inorganic Compounds.
Company details
Panacea Life Sciences Limited is recognized for its involvement in the manufacturing and trading of drugs, pharmaceuticals, diagnostics, and medicines, while also dealing in organic and inorganic substances, compounds, and chemicals. Operations are managed from offices in New Delhi, India, where various allied services are provided to support these activities. The company maintains a focus on these sectors, ensuring compliance with relevant policies and terms as outlined in their documentation. This structure facilitates the handling of products and services in a structured manner.
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Social LinkedIn X Facebook Instagram
- Legal Name Panacea Life Sciences Limited
- Date of Incorporation 20 May, 2016
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹20.85 Cr
FY 2025 · -9% YoY
- Indian entity net loss-₹8.3 Lakh
FY 2025 · 0% margin
- Indian entity EBITDA-₹23,000
FY 2025 · 0% margin
Associated legal entities of Panacea Life Sciences Limited
Panacea Life Sciences Limited operates through Panacea Life Sciences Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Panacea Life Sciences Limited CIN U74995DL2016PLC300077 | Active | 20 May 2016 | New Delhi, Delhi | ₹20.9 Cr | 1 | 7 | View details |
Products & Services of Panacea Life Sciences Limited
Panacea Life Sciences Limited offers a comprehensive portfolio of products and services, including Drugs and Pharmaceuticals and Chemicals.
Manufacturing and trading of drugs and pharmaceuticals are undertaken for supply purposes.
Dealing in organic and inorganic substances, compounds, and chemicals is conducted as part of allied services.
Board of directors of Panacea Life Sciences Limited (Panacea Life Sciences Limited)
Panacea Life Sciences Limited is the primary company behind Panacea Life Sciences Limited. The board of Panacea Life Sciences Limited currently have 7 directors; the longest-serving is Pradip Jain, appointed in 2016. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pradip Jain DIN 00336144 | Director | 20 May 2016 | 10 yrs 5 mo | Panacea Life Sciences Limited |
| Sumit Jain DIN 00014236 | Director | 04 Jul 2016 | 10 yrs 3 mo | Panacea Life Sciences Limited |
| Radhika Jain DIN 03592238 | Director | 26 Feb 2018 | 8 yrs 7 mo | Panacea Life Sciences Limited |
| Shilpy Jain DIN 08165713 | Director | 26 Feb 2021 | 5 yrs 7 mo | Panacea Life Sciences Limited |
| Sunanda Jain DIN 03592692 | Director | 27 Jul 2021 | 5 yrs 2 mo | Panacea Life Sciences Limited |
| Ganesh Kumraj DIN 02273847 | Director | 10 Mar 2022 | 4 yrs 7 mo | Panacea Life Sciences Limited |
| Nipun Jain DIN 09698442 | Director | 08 Aug 2022 | 4 yrs 2 mo | Panacea Life Sciences Limited |
Financials of Panacea Life Sciences Limited
Figures of Panacea Life Sciences Limited, the primary company behind Panacea Life Sciences Limited, for FY 2025. Revenue was ₹20.85 Cr (-9% year on year). Net loss was -₹8.3 Lakh (0% margin). EBITDA was -₹23,000 (0% margin). Revenue has grown at a compounded annual rate of +30% over three years and +406% over five years.
- ₹20.85 CrRevenue · FY 2025 · -9% YoY
- -₹8.3 LakhNet loss · 0% margin
- -₹23,000EBITDA · 0% margin
- ₹20 LakhPaid-up capital
- 1Employees (provident fund records)
- +30%Revenue CAGR, 3 years
- +406%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Panacea Life Sciences Limited are on its company page.
Detailed financial statements for Panacea Life Sciences Limited
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Panacea Life Sciences Limited
The primary company behind Panacea Life Sciences Limited, Panacea Life Sciences Limited, reported revenue of ₹20.85 Cr for FY 2025, down 9% year on year.
Panacea Life Sciences Limited is recognized for its involvement in the manufacturing and trading of drugs, pharmaceuticals, diagnostics, and medicines, while also dealing in organic and inorganic substances, compounds, and chemicals. Operations are managed from offices in New Delhi, India, where various allied services are provided to support these activities. The company maintains a focus on these sectors, ensuring compliance with relevant policies and terms as outlined in their documentation. This structure facilitates the handling of products and services in a structured manner.
Panacea Life Sciences Limited offers Drugs and Pharmaceuticals and Chemicals.
Panacea Life Sciences Limited operates through Panacea Life Sciences Limited.
The legal entities of Panacea Life Sciences Limited currently have 7 directors, including Ganesh Kumraj, Shilpy Jain, Nipun Jain and others.